Variable Name | Mean ± SD/Median or % | Variable Name | Percentage |
---|---|---|---|
Survival (month) | 33.8 ± 29.4/25.3 | Event | |
Disease free survival (month) | 25.0 ± 28.9/11.7 | Deceased | 32.2 |
Age (year) | 56.0 ± 12.0/56 | Censored | 67.8 |
Male | 80.4% | Child's grade | |
Liver Function Parameters | A | 97.3 | |
AFP [log10] (ng/mL) | 2.18 ± 1.39/2.03 | B | 2.7 |
SGPT (U/L) | 61.0 ± 51.4/46 | Family History of HCC | 20.7 |
SGOT (U/L) | 64.3 ± 53.9/49 | Smoking | |
BILIRUBIN (μM) | 14.5 ± 11.2/12 | No | 55.6 |
ALBUMIN (mg/mL) | 40.2 ± 4.7/41 | Moderate | 30.5 |
Heavy | 13.9 | ||
Tumor Size (cm) | 7.6 ± 4.1/6.5 | Alcohol Drinking | |
Tumor Recurrence | 51.1% | No | 60.5 |
Venous Infiltration | Moderate | 23.3 | |
Absence | 50.6% | Heavy | 16.2 |
Presence | 49.4% | No. of tumor nodule(s) | |
Non-tumorous liver histology | 1 | 76.3 | |
Cirrhotic | 57.1% | 2 | 6.8 |
Non-cirrhotic | 14.0% | 3 | 1.5 |
Chronic hepatitis | 28.9% | 4 | 1.1 |
pTNM Stage | 5 | 0.4 | |
I | 3.0% | 6 | 0.8 |
II | 41.1% | Multiple >6 | 13.2 |
IIIA | 35.5% | Edmondson Grade | |
IV | 20.3% | Undifferentiated | 1.3 |
AJCC Stage | Poorly Differentiated | 18.3 | |
I | 41.5% | Moderate Differentiated | 59.2 |
II | 27.9% | Well Differentiated | 21.3 |
IIIA | 21.9% | HBsAg Status | |
IIIB | 7.5% | Positive | 86.1 |
IV | 1.1% | Negative | 13.9 |